Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial

Lorinda Chung, Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton, Jerry A. Molitor, Virginia Steen, Robert Lafyatis, Robert W. Simms, Suzanne Kafaja, Tracy Frech, Vivien Hsu, Robyn T. Domsic, Janet Pope, Jessica Gordon, Maureen D. Mayes, Nora Sandorfi, Faye N. Hant, Elana J. Bernstein, Soumya Chatterjee, Flavia V. Castelino, Ali Ajam, Yannick Allanore, Marco Matucci‐Cerinic, Michael L. Whitfield, Oliver Distler, Ora Singer, Amber Young, Vivek Nagaraja, David A. Fox, Daniel E. Furst, Dinesh Khanna